McDonald Partners’s GSK GSK Stock Holding History

McDonald Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.2K	Buy	+920	New	+$48.7K	0.01%	324
2022 Q3	–	Sell	-3,918	Closed	-$213K	–	241
2022 Q2	$213K	Buy	3,918 +1	+0%	+$55	0.05%	274
2022 Q1	$213K	Buy	+3,917	New	+$213K	0.05%	289
2021 Q4	–	Sell	-6,482	Closed	-$310K	–	616
2021 Q3	$310K	Buy	6,482 +1,122	+21%	+$56.4K	0.07%	245
2021 Q2	$267K	Buy	5,360 +402	+8%	+$19.3K	0.06%	258
2021 Q1	$221K	Buy	4,958 +1	+0%	+$45	0.06%	267
2020 Q4	$228K	Buy	+4,957	New	+$228K	0.06%	252

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

McDonald Partners's GSK Position: Q2 2026 in Review

McDonald Partners opened a new position in GSK (GSK) in Q2 2026: 920 shares worth $48.2K. The stake represents 0.01% of the portfolio and ranks #324 among its holdings. This is a return to the name: McDonald Partners previously reported a position in GSK as recently as Q2 2022.

McDonald Partners first reported a position in GSK in Q4 2020 and has held it in 7 quarters since. The position peaked at $310K in Q3 2021. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

McDonald Partners held 920 shares of GSK worth $48.2K as of Q2 2026.
GSK was a new McDonald Partners position in Q2 2026.
GSK made up 0.01% of McDonald Partners's portfolio in Q2 2026, its #324 holding.
McDonald Partners first reported a position in GSK in Q4 2020 and has held it in 7 quarters since.
McDonald Partners's GSK position peaked at $310K in Q3 2021.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on McDonald Partners's 13F filing for Q2 2026, filed 28 Jul 2026.